West Pharmaceutical Services, Inc.
WST
$355.64
$1.530.43%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 601.80M | 853.90M | 898.60M | 796.30M | 886.30M |
| Total Receivables | 543.90M | 533.50M | 539.00M | 555.80M | 532.80M |
| Inventory | 429.90M | 434.70M | 431.80M | 449.40M | 447.00M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 117.30M | 114.30M | 102.90M | 72.70M | 71.10M |
| Total Current Assets | 1.69B | 1.94B | 1.97B | 1.87B | 1.94B |
|
|
|||||
| Total Current Assets | 1.69B | 1.94B | 1.97B | 1.87B | 1.94B |
| Net Property, Plant & Equipment | 1.55B | 1.51B | 1.41B | 1.36B | 1.32B |
| Long-term Investments | 107.60M | 108.50M | 106.80M | 108.00M | 107.80M |
| Goodwill | 107.60M | 108.50M | 106.80M | 108.00M | 107.80M |
| Total Other Intangibles | 13.90M | 15.10M | 15.70M | 16.80M | 17.80M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 40.00M | 47.00M | 56.10M | 107.30M | 135.70M |
| Total Assets | 3.60B | 3.83B | 3.75B | 3.67B | 3.72B |
|
|
|||||
| Total Accounts Payable | 240.10M | 242.40M | 219.80M | 218.00M | 233.80M |
| Total Accrued Expenses | 66.50M | 156.10M | 90.50M | 85.40M | 65.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 151.40M | 151.70M | 71.70M | 18.40M | 18.40M |
| Total Finance Division Other Current Liabilities | 190.40M | 121.60M | 151.50M | 189.80M | 217.00M |
| Total Other Current Liabilities | 190.40M | 121.60M | 151.50M | 189.80M | 217.00M |
| Total Current Liabilities | 648.40M | 671.80M | 533.50M | 511.60M | 534.90M |
|
|
|||||
| Total Current Liabilities | 648.40M | 671.80M | 533.50M | 511.60M | 534.90M |
| Long-Term Debt | 72.80M | 72.80M | 152.10M | 205.60M | 206.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 82.40M | 84.50M | 83.00M | 87.30M | 89.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 118.10M | 119.40M | 117.90M | 118.40M | 116.50M |
| Total Liabilities | 921.70M | 948.50M | 886.50M | 922.90M | 947.40M |
|
|
|||||
| Common Stock & APIC | 74.00M | 139.00M | 141.40M | 177.00M | 200.20M |
| Retained Earnings | 3.62B | 3.52B | 3.42B | 3.25B | 3.11B |
| Treasury Stock & Other | -1.02B | -781.40M | -689.10M | -684.90M | -537.60M |
| Total Common Equity | 2.68B | 2.88B | 2.87B | 2.75B | 2.78B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.68B | 2.88B | 2.87B | 2.75B | 2.78B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.68B | 2.88B | 2.87B | 2.75B | 2.78B |
|
|
|||||
